{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T06:27:17Z","timestamp":1772346437345,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.bcmd.2005.11.002","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T08:26:54Z","timestamp":1136449614000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Iron chelation treatment with combined therapy with deferiprone and deferioxamine: A 12-month trial"],"prefix":"10.1016","volume":"36","author":[{"given":"Antonis","family":"Kattamis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Ladis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Berdousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos L.","family":"Kelekis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthymia","family":"Alexopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Papasotiriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Drakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irini","family":"Kaloumenou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aggeliki","family":"Galani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Kattamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2005.11.002_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","article-title":"Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major","volume":"331","author":"Brittenham","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2005.11.002_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199409013310903","article-title":"Survival in medically treated patients with homozygous beta-thalassemia","volume":"331","author":"Olivieri","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2005.11.002_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","article-title":"Role of deferiprone in chelation therapy for transfusional iron overload","volume":"102","author":"Hoffbrand","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2005.11.002_bib4","first-page":"1423","article-title":"Combined therapy with desferrioxamine and deferiprone in thalassemic patients: effect on urinary iron excretion","volume":"88","author":"Kattamis","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2005.11.002_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0037-1963(01)90030-7","article-title":"Chelation therapy in beta-thalassemia: an optimistic update","volume":"38","author":"Giardina","year":"2001","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcmd.2005.11.002_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.thj.6200550","article-title":"Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone","volume":"5","author":"Alymara","year":"2004","journal-title":"Hematol. J."},{"key":"10.1016\/j.bcmd.2005.11.002_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1365-2141.2003.04240.x","article-title":"Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients","volume":"121","author":"Mourad","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.11.002_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2141.1998.01002.x","article-title":"Combined therapy with deferiprone and desferrioxamine","volume":"103","author":"Wonke","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.11.002_bib9","first-page":"ELT07","article-title":"Combined chelation therapy with deferiprone and desferrioxamine in iron overloaded beta-thalassemia patients","volume":"89","author":"Athanassiou-Metaxa","year":"2004","journal-title":"Haematologica"},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2005.11.002_bib10","first-page":"79","article-title":"Combined chelation therapy in patients with thalassemia major: a fast and effective method of reducing ferritin levels and cardiological complications","volume":"3","author":"Farmaki","year":"2002","journal-title":"Hematol. J."},{"key":"10.1016\/j.bcmd.2005.11.002_bib11","series-title":"9th International Conference on Thalassemia and Hemoglobinopathies","first-page":"O48","article-title":"Combination therapy with desferrioxamine and deferiprone in thalassemia major","author":"Origa","year":"2003"},{"key":"10.1016\/j.bcmd.2005.11.002_bib12","unstructured":"E. Alexopoulou, F. Stripeli, P. Mparas, I. Seimenis, A. Kattamis, V. Ladis, E. Efstathopoulos, E.N. Brountzos, A.D. Kelekis, N.L. Kelekis, R2 Relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients, JMRI (in press)."},{"key":"10.1016\/j.bcmd.2005.11.002_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2141.1995.tb05274.x","article-title":"Results of long-term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators","volume":"91","author":"al-Refaie","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.11.002_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb03318.x","article-title":"Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload","volume":"89","author":"al-Refaie","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.11.002_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/clpt.1990.147","article-title":"Pharmacokinetic studies in humans with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one","volume":"48","author":"Kontoghiorghes","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcmd.2005.11.002_bib16","first-page":"604","article-title":"Optimizing chelation therapy: combining deferiprone and desferrioxamine","volume":"96","author":"Grady","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2005.11.002_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1365-2141.1999.01447.x","article-title":"Transport of 14C-deferiprone in normal, thalassaemic and sickle red blood cells","volume":"105","author":"Shalev","year":"1999","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.11.002_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1067\/mlc.2001.116487","article-title":"Exploring the \u201ciron shuttle\u201d hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture","volume":"138","author":"Link","year":"2001","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.bcmd.2005.11.002_bib19","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1182\/blood.V97.3.792","article-title":"Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy","volume":"97","author":"Breuer","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2005.11.002_bib20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2004.04946.x","article-title":"Purging iron from the heart","volume":"125","author":"Hershko","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.11.002_bib21","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia","volume":"360","author":"Anderson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2005.11.002_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/bcmd.2002.0510","article-title":"Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial","volume":"28","author":"Maggio","year":"2002","journal-title":"Blood Cells Mol. Diseases"},{"key":"10.1016\/j.bcmd.2005.11.002_bib23","first-page":"489","article-title":"Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis","volume":"88","author":"Piga","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2005.11.002_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1163\/15685590160141369","article-title":"Effect of oral iron chelation therapy with deferiprone (L1) on the psychosocial status of thalassaemia patients","volume":"31","author":"Zahed","year":"2002","journal-title":"Haematologia (Bp)"},{"key":"10.1016\/j.bcmd.2005.11.002_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2141.2002.03554.x","article-title":"The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients","volume":"118","author":"Ceci","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2005.11.002_bib26","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2002-10-3280","article-title":"Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone","volume":"102","author":"Cohen","year":"2003","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979605001919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979605001919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:21:43Z","timestamp":1761049303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979605001919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1079979605001919"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2005.11.002","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron chelation treatment with combined therapy with deferiprone and deferioxamine: A 12-month trial","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2005.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}